Maximum quantity allowed is 999
请选择数量
CAS RN: 188817-13-2 | 产品编码: C3572
SC-560

产品编码 | C3572 |
纯度/分析方法 ![]() |
>98.0%(HPLC) |
分子式/分子量 | C__1__7H__1__2ClF__3N__2O = 352.74 |
外观与形状(20°C) | 固体 |
储存温度 ![]() |
冷藏 (0-10°C) |
应避免的情况 | 加热 |
包装和容器 ![]() |
25MG-Glass Bottle with Plastic Insert (查看图片) |
CAS RN | 188817-13-2 |
Reaxys-RN | 7719788 |
PubChem物质ID | 468591169 |
MDL编号 | MFCD02179214 |
技术规格
Appearance | White to Light yellow to Light orange powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Elemental analysis(Nitrogen) | 7.50 to 8.50 % |
Melting point | 61.0 to 65.0 °C |
物性(参考值)
熔点 | 63 °C |
GHS
相关法规
RTECS# | UQ6457100 |
运输信息
HS编码* | 2933.19-000 |
应用
SC-560: A Selective Cyclooxygenase-1 (COX-1) Inhibitor
SC-560 is a strucutral analog of celecoxib [C2816] and a member of cyclooxygenase (COX) inhibitors which includes selective COX-2 inhibitors such as celecoxib and rofecoxib [R0206]. However, unlike these selective COX-2 inhibitors, SC-560 is a selective COX-1 inhibitor. Reportedly, SC-560 causes intestinal hypermotility, bacterial invasion, inhibition of prostaglandin E2 synthesis, etc. In addition, SC-560 suppresses cell proliferation and induces apoptosis in cancer cells in the blood. (The product is for research purpose only.)
References
- Pharmacological analysis of cyclooxygenase-1 in inflammation
- NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2
- Inhibition of prostaglandin E2 synthesis by SC-560 is independent of cyclooxygenase 1 inhibition
- Selective COX-1 inhibition: a therapeutic target to be reconsidered (a review)
- The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells
技术文章
产品文档 (部分产品的分析图谱无法提供,敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助,请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注:该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉,您搜索的分析图谱无法提供。